Who regulates what in India

India divides financial regulation by what the product is, not by what it is for. That single design choice explains most of what follows.

The division

Regulator	Covers
SEBI	Securities markets — stocks, bonds, mutual funds, brokers, investment advisers, research analysts, exchanges
RBI	Banks, non-banking financial companies, payments, monetary policy, government debt
IRDAI	Insurance — life, general, health, and the insurers and intermediaries selling it
PFRDA	Pensions, chiefly the National Pension System

SEBI's remit comes from the statute read in chapter 1: section 11(2) lists stock exchanges, intermediaries including investment advisers, depositories, credit rating agencies, mutual funds and collective investment schemes, and the prohibition of fraudulent and unfair trade practices.

The RBI's remit is unusually wide: as the Financial institutions subject set out, it regulates banks, sets monetary policy, manages the government's borrowing and acts as lender of last resort. Combining those in one institution concentrates information usefully and concentrates conflicts too — the body pursuing the inflation target is also the government's debt manager.

The consequence: division by product, not by purpose

A household does not have a securities need and a separate insurance need. It has purposes — retire, educate a child, survive a hospital bill, cope with the earner dying.

For almost any purpose, several products compete, and they sit under different regulators:

Purpose	Candidate products	Regulators involved
Lump sum in twenty years	Mutual fund, ULIP, endowment policy, bank deposit, NPS	SEBI, IRDAI, RBI, PFRDA
Income in retirement	Annuity, NPS, debt fund, deposit	IRDAI, PFRDA, SEBI, RBI
Protection on death	Term insurance	IRDAI

So the buyer comparing options is comparing across regulatory regimes, with different disclosure rules, different charge conventions, different commission structures and different complaint machinery — while believing they are comparing products.

Regulatory arbitrage

Where two regimes govern substitutable products, firms face a predictable incentive: design the product under whichever regime is more accommodating.

This is not an accusation of wrongdoing; it is a structural fact. If one regime requires a charge to be shown as a percentage and the other allows it inside a projected maturity value, products that need to hide charges will tend to be built under the second. If one caps commissions and the other does not, distribution effort will flow to the uncapped one — and distribution effort is what determines what gets offered to you.

Where the regimes meet is therefore where to be most careful, and the clearest example in India is the investment-plus-insurance product, which is a bundle precisely at the seam.

What coordinates them

Regulators are not isolated. The Financial Stability and Development Council exists to coordinate across them, the RBI's financial stability work looks across sectors, and some regimes borrow each other's concepts — chapter 9's mis-selling definition, for instance, is written in terms of suitability, which is the same idea the adviser rules in chapter 5 use.

Coordination is real and partial. The honest statement is that no single body is accountable for whether a household ends up with a sensible overall arrangement, because no regulator's mandate is defined in those terms.

Working the problem

Two products aiming at a lump sum in twenty years, under SEBI and IRDAI.

What follows from the different regulators:

Different disclosure conventions. Fund charges are expressed as an annual percentage of assets on a standard basis, which makes them comparable across funds. Insurance-linked charges are typically several distinct deductions, and the headline presentation is often a projected maturity value rather than a cost. Comparing a percentage with a projection is not a comparison.

Different commission structures, and therefore different selling pressure. Where the two products compete for the same rupee, the one paying distributors more will reach you more often. What you are offered is not a sample of what exists.

Different complaint routes. Separate grievance systems and separate ombudsman arrangements, which matters when something goes wrong and matters not at all at the point of sale — which is when you choose.

Different exit terms. Fund units are generally redeemable at net asset value; a long-dated insurance contract may return substantially less than paid if surrendered early. Two products with the same stated goal can differ enormously in what happens if your life changes, and your life will change.

What I would check before treating them as comparable:

1. Total cost over the holding period in rupees, not percentages and not projections. If a seller cannot or will not produce this, that is the answer to the question.
2. The value on exit at year 3, 5 and 10, not only at maturity.
3. Whether the product bundles protection with investment, and what the same protection would cost bought separately as term cover — because the bundle's cost is only assessable against the unbundled alternative.
4. The regulator and the registration number, verified on that regulator's own site rather than from the brochure.
5. Who is paid what for selling it to me. Chapter 5 explains why the answer to this predicts the recommendation better than anything else on the list.

The point

India regulates by product — SEBI for securities, RBI for banks and NBFCs, IRDAI for insurance, PFRDA for pensions — while households buy by purpose, so almost any goal can be met by instruments supervised under different regimes with different disclosure, charge and exit conventions. That creates a standing incentive to build a product under whichever regime is more accommodating, which is why the seams between regimes, above all the investment-plus-insurance bundle, deserve the most care. Coordination between regulators exists, but no one body is answerable for whether your overall arrangement makes sense.